Peter Gocze
Overview
Explore the profile of Peter Gocze including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalincsak J, Gocze P, Bohonyi N, Bardos N, Koppan M, Kovacs K, et al.
Orv Hetil
. 2020 Mar;
161(11):425-433.
PMID: 32148096
Endometrial cancer is the most common invasive gynecologic malignancy in developed countries. The best survival rates are expected after surgical removal, thus the aim of a complex treatment is to...
2.
Kalincsak J, Gocze P, Bodis J, Kovacs K, Stefanovits A, Bohonyi N, et al.
Orv Hetil
. 2018 May;
159(19):741-747.
PMID: 29730944
Introduction And Aim: The aim of our study was to evaluate the prognostic factors and treatment options of a very rare and highly aggressive type of uterine neoplasms, the malignant...
3.
Mangel L, Biro K, Battyani I, Gocze P, Tornoczky T, Kalman E
BMC Cancer
. 2015 Dec;
15:1013.
PMID: 26704433
Background: Treatment possibilities of metastatic renal cell carcinoma (mRCC) have recently changed dramatically prolonging the overall survival of the patients. This kind of development brings new challenges for the care...
4.
Gocze K, Gombos K, Kovacs K, Juhasz K, Gocze P, Kiss I
Anticancer Res
. 2015 Jan;
35(1):523-30.
PMID: 25550598
Background/aim: The role of oncogenic or high-risk human papillomavirus (HPV) in cervical carcinogenesis is inevitable, yet not fully understood. Detailed analysis of microRNA (miRNA) alterations occurring during high-risk HPV transformation...
5.
Hatzipetros I, Gocze P, Koszegi T, Jaray A, Szereday L, Polgar B, et al.
J Ovarian Res
. 2013 Nov;
6(1):79.
PMID: 24238270
Objective: Recently, 14-3-3 zeta protein was identified as a potential serum biomarker of epithelial ovarian cancer (EOC). The goal of this study was to investigate the clinical potential of 14-3-3...
6.
Gocze K, Gombos K, Juhasz K, Kovacs K, Kajtar B, Benczik M, et al.
Anticancer Res
. 2013 Jun;
33(6):2561-7.
PMID: 23749909
Cervical cancer is the second leading cause of death among female patients with cancer in the world. Our aim was to analyze cervical cancer cases, in the Southwestern Transdanubian Region...
7.
Marek E, Dergez T, Rebek-Nagy G, Szilard I, Kiss I, Ember I, et al.
Vaccine
. 2012 Sep;
30(48):6824-32.
PMID: 23000124
The alarming national data on the mortality and morbidity rates of cervical cancer as well as the results of a Hungarian survey demonstrating adolescents' low level of understanding of human...
8.
Nagy P, Toth Z, Gocze P, Adam L
Orv Hetil
. 2012 Mar;
153(11):435-7.
PMID: 22390868
This report presents the history of a 35-year-old patient with adenoid cystic cervical cancer stage IIIB. Adenoid cystic carcinoma of the uterine cervix is a rare disease with poor prognosis....
9.
Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S, et al.
Vaccine
. 2011 Sep;
29(47):8591-8.
PMID: 21939711
Hungary takes the fourth place regarding the incidence and the fifth regarding the mortality of cervical cancer among the member countries of the European Union, with 500 deaths due to...
10.
Marek E, Dergez T, Kricskovics A, Kovacs K, Rebek-Nagy G, Gocze K, et al.
Vaccine
. 2011 Jun;
29(32):5122-9.
PMID: 21624417
Cervical cancer is one of the most prevalent gynaecological malignancies worldwide. The Hungarian incidence and mortality of this disease take the 4th-5th places within the European Union. A survey including...